Phibro Animal Health | PAHC - Devedores Comerciais





Devedores Comerciais Alterar Data
Align Technology USD 1.13B 23.36M 2026-03
ANI Pharmaceuticals USD 255.43M 25.65M 2026-03
Assertio Holdings USD 39.91M 2.7M 2024-06
Aurora Cannabis CAD 48.26M 1.53M 2025-12
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Canopy Growth CAD 140.42M 113.56M 2025-12
Corcept Therapeutics USD 39.07M 20.71M 2026-03
Eli Lilly USD 21.18B 1.02B 2026-03
Henry Schein USD 1.72B 68M 2026-03
Idexx Laboratories USD 697.21M 144.83M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
Merck USD 11.78B 345M 2025-12
Nektar Therapeutics USD 1.78M 1.12M 2025-12
Pacira USD 125.64M 1.57M 2026-03
Phibro Animal Health USD 215.87M 2.02M 2025-12
Prestige Brands USD 191.92M 1.46M 2026-03
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
Zoetis USD 1.51B 84M 2026-03